- Global Pharma News & Resources

US Pet Products and Services are Expected to Reach 100 Billion in Sales for 2020, the Over-the-Counter Pet Meds are a Huge Percentage of Consumer Spending

NEW YORK, July 7, 2020 /PRNewswire/ -- Goldman Pharmaceutical Group announces that its full lineup of over-the-counter pet medications include: NausX, an anti-emetic medication designed for dogs with motion sickness which include nausea, dizziness and vomiting; Calmatrol, an anti-histamine medication designed to relieve dogs in stress related circumstances bringing instant relief to your dog; and DIFIXN, an anti-diarrheal treatment designed to relieve dogs with diarrhea.

American Pet Products Association (APPA) announced in February of this year that the U.S. is expected to reach a record 100 billion in sales for pet products and services. The CEO, Steve King of the American Pet Products Association (APPA), reported that U.S. sales of pet products and services are nearing $100 billion for the first time, as 2019 spending reached $95.7 billion. The announcement came during Global Pet Expo, the largest annual pet products trade show presented by APPA and the Pet Industry Distributors Association (PIDA). APPA's pet industry expenditures encompass spending in four major categories: Pet Food & Treats; Supplies, Live Animals & OTC (over-the-counter) Medicine; Vet Care & Product Sales; and Other Services.

"Scientific research from the Human Animal Bond Research Institute (HABRI) shows that when you invest in your pets' health, you're investing in your own health," said King. "Improved physical health and reduced feelings of loneliness and social isolation are just a few of the health benefits you're likely to experience by owning a pet."

Goldman Pharmaceutical Group understands that motion sickness in dogs is a common problem… before you know it, your furry best friend's breakfast can end up all over your backseat! 

NausX by Pet OTC™ is the ultimate treatment for canine motion sickness. It's a powerful preventative when taken before a trip, and a fast-acting remedy to treat sudden symptoms immediately. Some of the signs and symptoms of motion sickness in dogs include:

  • Uneasiness
  • Dizziness
  • Drooling
  • Whining
  • Vomiting
  • Excessive Smacking/Licking

Goldman Pharmaceutical Group created Calmatrol as a calming formula that reduces anxiety and stress in dogs and puppies for a much more confident and relaxed pet. Calmatrol by Pet OTC™ will soothe anxious dogs and alleviate symptoms of:

  • Pacing
  • Restlessness
  • Panting
  • Whining
  • Not Eating
  • Hiding
  • Chewing, Scratching
  • Urinating in House

The Calmatrol treatment by Pet OTC™ is formulated to encourage canine calmness android behavior, while helping your fury friend overcome feelings of nervousness, agitation and aggression.

The last of the over-the-counter pet treatments manufactured by Goldman Pharmaceutical Group is Difixn by Pet OTC™ an anti-diarrheal treatment that works fast to relieve dogs of the symptoms of Diarrhea.

Pet OTC™ Products:

  • No Prescriptions Needed
  • Veterinarian Recommended
  • FDA Registered
  • Made in the USA

Associated Press American Pet Products Association (APPA) press release cited, visit for more information.

About American Pet Products Association (APPA) 

The American Pet Products Association is the leading trade association serving the interests of the pet products industry since 1958.  APPA membership includes more than 1,100 pet product manufacturers, their representatives, importers and livestock suppliers representing both large corporations and growing business enterprises.  APPA's mission is to promote, develop and advance pet ownership and the pet product industry and to provide the services necessary to help its members prosper. APPA is also proud to grow and support the industry through the following initiatives: Pets Add Life (PAL), Tony La Russa's Animal Rescue Foundation (ARF) Pets and Vets Program, the Human Animal Bond Research Institute (HABRI), the Pet Industry Joint Advisory Council (PIJAC), Bird Enjoyment and Advantage Koalition (BEAK), and the Pet Care Trust.  Visit for more information.

About Goldman Pharmaceutical Group (GPG)

Goldman Pharmaceutical Group is concerned with the overall health and well being of people and animals. GPG develops and markets products dedicated  to  human and animal health and safety. The company markets  disinfectants,  diagnostic test kits to  detect  viral bacteria, allergens, teeth and oral care, fungal nail treatments, acne skincare, luggage technology, pet food, pet wellness aids, and over-the-counter pet treatments. Goldman Pharmaceutical Group is a leader in contract manufacturing and distribution of  a  variety of animal healthcare products, including diagnostics, pharmaceuticals, wound care and disinfectants.

GPG started as a pharmaceutical repacking company focusing mainly on private labeling. Their mission is to continuously innovate and bring new products to market within the medical and pharmaceutical industries, while upholding and creating strong relationships with their clientele and the public. Visit for more information. Exclusive Manufacturer and Distributor for Pet OTC™ Products.

Contact Information for Goldman Pharmaceutical Group and Pet OTC™:
Jeff Magsitza

Media Contact:
Annamarie Seabright, Publicist
Signature |PR
A Public Relations & Digital Marketing Agency in California and New York


View original content to download multimedia:

SOURCE Goldman Pharmaceutical Group

US Pet Products and Services are Expected to Reach 100 Billion in Sales for 2020, the Over-the-Counter Pet Meds are a Huge Percentage of Consumer Spending

Editor Details

Last Updated: 07-Jul-2020